Pharma Focus Asia
KP - Choose our fully recyclable blister films

MagBio Launches its Novel cfKapture 21 Kit

MagBio Genomics announces the launch of its new cfKapture 21 kit. cfKapture 21 kit is said to be a novel solution for isolation of circulating Cell-Free DNA (ccfDNA) from stabilized plasma sample.

cfKapture 21 system is a ccfDNA isolation kit which includes a proprietary reagent that prevents post-separation degradation of plasma and ccfDNA fragments for up to 21 days at room temperature.

Laboratories can easily and safely transport process samples within a much longer time frame without the requirement for extensive cold chain through this feature. It also reduces cost, enhances efficiency, and also increases outreach for both local and international samples.

cfKapture 21 is the only kit on the market able to provide this level of flexibility for processing plasma samples in a high throughput setting.

It is compatible with any whole blood collection tube. In addition, it can be used in combination with the MagBio Blood STASIS 21-ccfDNA tube to ensure recovery of the maximum quality ccfDNA appropriate for most liquid biopsy applications.

Blood STASIS 21-ccfDNA is a direct draw whole blood collection system with a proprietary blood stabilization reagent, compatible with almost all liquid biopsy applications for cancer genomic research and Non-invasive Prenatal testing (NIPT).

The MagBio cfKapture 21 kit offers a cost effective solution to blood sampling and ccdDNA isolation using MagBio's Blood STASIS 21- ccfDNA tube.

In order to maintain the integrity of ccfDNA within the samples they have to be shipped frozen with dry ice for the duration of the transport cycle. The samples of plasma are used for ccfDNA.

Because stabilizing plasma samples during transport remains a major hurdle in obtaining meaningful data from ccfDNA, MagBio developed the cfKapture 21 purification kit to overcome this challenge.

The MagBio cfKapture 21 kit includes a reagent that allows short-term transport and storage of separated plasma at room temperature for 21 days while maintaining the stability of ccfDNA.  

As it contains the unique feature, cfKapture21 provides flexibility in plasma sample processing as well as significant cost savings associated with sample handling in both manual and automated ccfDNA isolation settings.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoBora Pharmaceuticals - Free WhitepaperThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 2023Reuters Events - Pharma Customer Engagement USA 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023
MasterControl - 6 Essential Features in an eQMS